Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Self-Evaluation Maintenance Model01:29

Self-Evaluation Maintenance Model

303
The Self-Evaluation Maintenance (SEM) model offers a psychological framework to understand how individuals’ self-esteem is influenced by the achievements of others, particularly those with whom they share close personal bonds. The SEM model operates when personal rather than social identity guides individuals. Central to this model is the notion that individuals have an inherent desire to preserve a favorable self-image, which is continuously shaped by interpersonal comparisons and...
303
Group Therapy01:26

Group Therapy

433
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
433
Acute Pharyngitis01:30

Acute Pharyngitis

4.2K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.2K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Blood cancer discovery·2026
Same author

Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.

Transplantation and cellular therapy·2026
Same author

Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy.

Leukemia & lymphoma·2026
Same author

Cytokine release syndrome after allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide: current understanding and management.

Frontiers in immunology·2026
Same author

Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies.

Blood cancer journal·2026
Same author

Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donor.

Blood advances·2026

Related Experiment Video

Updated: Jan 31, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

685

Posttransplant maintenance therapy for acute leukemias.

Shyam K Poudel1, Marcos de Lima, Leland Metheny

  • 1Stem Cell Transplant Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.

Current Opinion in Hematology
|January 10, 2019
PubMed
Summary

Maintenance therapy after allogeneic stem cell transplant may reduce leukemia recurrence. Ongoing trials investigate epigenetic modifiers, tyrosine kinase inhibitors, and antibody-drug conjugates for preventing relapse in hematological malignancies.

More Related Videos

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

513
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.6K

Related Experiment Videos

Last Updated: Jan 31, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

685
In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

513
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.6K

Area of Science:

  • Hematology and Oncology
  • Transplantation Immunology

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for many hematological malignancies.
  • Leukemia recurrence remains the primary cause of HSCT failure, influenced by minimal residual disease and prognostic factors.

Purpose of the Study:

  • To review current research on maintenance therapy strategies aimed at preventing acute leukemia recurrence post-allogeneic HSCT.
  • To explore novel therapeutic agents and approaches for reducing post-transplant leukemia relapse.

Main Methods:

  • Review of current scientific literature and clinical trial data on post-HSCT maintenance therapies for acute leukemias.
  • Analysis of emerging therapeutic classes including epigenetic modifiers, tyrosine kinase inhibitors, and antibody-drug conjugates.

Main Results:

  • Phase I/II clinical trial data for several novel maintenance therapies are maturing and show encouraging results.
  • Initiation of multicenter phase III randomized clinical trials signifies progress in validating these post-transplant strategies.

Conclusions:

  • No standard of care currently exists for post-HSCT maintenance in acute leukemias.
  • Further investigation into the efficacy and safety of maintenance therapies is crucial.
  • Targeted cellular therapies, such as chimeric antigen receptor T cells, represent a promising future direction beyond conventional chemo-immunotherapy.